Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Scuderi, Caterina ^a   Valenza, Marta ^b   Stecca, Claudia ^a   Esposito, Giuseppe ^a   Carratù, Maria R ^b   Steardo, Luca ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Hippocampal organotypic culture; Neuroprotection; Palmitoylethanolamide; PPAR ; amyloid

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; ENZYME INHIBITOR; GLIAL FIBRILLARY ACIDIC PROTEIN; INDOLE DERIVATIVE; MICROTUBULE ASSOCIATED PROTEIN; NEUROPROTECTIVE AGENT; PALMITIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BRAIN SLICE; CELL ACTIVATION; CELL LOSS; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EMBRYO; FEMALE; GLIA; GLIOSIS; HIPPOCAMPUS; INFLAMMATION; MIXED CELL CULTURE; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; ANIMAL EMBRYO; APOPTOSIS; BRAIN; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG ANTAGONISM; IN VITRO STUDY; METABOLISM; NERVE CELL; NEWBORN; ORGAN CULTURE TECHNIQUE; SPRAGUE DAWLEY RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; INDOLES; MICROTUBULE-ASSOCIATED PROTEINS; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; PALMITIC ACIDS; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84857983911     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-49     Document Type: Article

References (26)

1. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006, 368:387-403. 10.1016/S0140-6736(06)69113-7, 16876668.
2. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934. 10.1016/j.cell.2010.02.016, 2873093, 20303880.
3. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med 2006, 12:1005-1015.
4. Mrak RE, Griffin WS. Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 2001, 22:903-908. 10.1016/S0197-4580(01)00287-1, 11754997.
5. Heneka MT, O'Banion MK, Terwel D, Kummer MP. Neuroinflammatory processes in Alzheimer's disease. Neural Transm 2010, 117:919-947.
6. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005, 76:77-98. 10.1016/j.pneurobio.2005.06.004, 16081203.
7. Hoareau L, Buyse M, Festy F, Ravanan P, Gonthier MP, Matias I, Petrosino S, Tallet F, d'Hellencourt CL, Cesari M, Di Marzo V, Roche R. Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. Obesity (Silver Spring) 2009, 17:431-438.
8. LoVerme J, La Rana G, Russo R, Calignano A, Piomelli D. The search for the palmitoylethanolamide receptor. Life Sci 2005, 77:1685-1698. 10.1016/j.lfs.2005.05.012, 15963531.
9. Solorzano C, Zhu C, Battista N, Astarita G, Lodola A, Rivara S, Mor M, Russo R, Maccarrone M, Antonietti F, Duranti A, Tontini A, Cuzzocrea S, Tarzia G, Piomelli D. Selective -acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc Natl Acad Sci USA 2009, 106:20966-20971. 10.1073/pnas.0907417106, 2791595, 19926854.
10. Landreth G. Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease. Curr Alzheimer Res 2007, 4:159-164. 10.2174/156720507780362092, 17430241.
11. Bright JJ, Kanakasabai S, Chearwae W, Chakraborty S. PPAR regulation of inflammatory signaling in CNS diseases. PPAR Res 2008, 2008:658520. 2490815, 18670616.
12. Klievwer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-ci retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 1992, 358:771-774. 10.1038/358771a0, 1324435.
13. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 1998, 395:137-143. 10.1038/25931, 9744270.
14. Hansen HS, Moesgaard B, Hansen HH, Petersen G. -Acylethanolamines and precursor phospholipids: relation to cell injury. Chem Phys Lipids 2000, 108:135-150. 10.1016/S0009-3084(00)00192-4, 11106787.
15. Walter L, Franklin A, Witting A, Moller T, Stella N. Astrocytes in culture produce anandamide and other acylethanolamides. J Biol Chem 2002, 277:20869-20876. 10.1074/jbc.M110813200, 11916961.
16. Muccioli GG, Stella N. Microglia produce and hydrolyze palmitoylethanolamide. Neuropharmacology 2008, 54:16-22. 10.1016/j.neuropharm.2007.05.015, 2254322, 17631917.
17. Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, Leon A. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci USA 1996, 93:3984-3989. 10.1073/pnas.93.9.3984, 39472, 8633002.
18. Franklin A, Parmentier-Batteur S, Walter L, Greenberg DA, Stella N. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci 2003, 23:7767-7775.
19. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-α mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 2005, 67:15-19. 10.1124/mol.104.006353, 15465922.
20. Heneka MT, Landreth GE. PPARs in the brain. Biochim Biophys Acta 2007, 1771:1031-1045.
21. Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Bramanti P, Piomelli D, Calignano A, Cuzzocrea S. Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J Pharmacol Exp Ther 2008, 326:12-23. 10.1124/jpet.108.136903, 18367664.
22. Hansen HS. Palmitoylethanolamide and other anandamide congeners: proposed role in the diseased brain. Exp Neurol 2010, 224:48-55. 10.1016/j.expneurol.2010.03.022, 20353771.
23. Scuderi C, Esposito G, Blasio A, Valenza M, Arietti P, Steardo L, Carnuccio R, De Filippis D, Petrosino S, Iuvone T, Di Marzo V, Steardo L. Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide. J Cell Mol Med 2011, 15:2664-2674. 10.1111/j.1582-4934.2011.01267.x, 21255263.
24. Vairano M, Dello Russo C, Pozzoli G, Battaglia A, Scambia G, Tringali G, Aloe-Spiriti MA, Preziosi P, Navarra P. Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur J Neurosci 2002, 16:584-592. 10.1046/j.1460-9568.2002.02125.x, 12270034.
25. Antonelli T, Tomasini MC, Fournier J, Mazza R, Tanganelli S, Pirondi S, Fuxe K, Luca F. Neurotensin receptor involvement in the rise of extracellular glutamate levels and apoptotic nerve cell death in primary cortical cultures after oxygen and glucose deprivation. Cereb Cortex 2008, 18:1748-1757. 10.1093/cercor/bhm217, 18063561.
26. Pellegrini-Giampietro DE, Cozzi A, Peruginelli F, Leonardi P, Meli E, Pellicciari R, Moroni F. 1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-3'-carboxybicyclo[1,1,1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia. Eur J Neurosci 1999, 11:3637-3647. 10.1046/j.1460-9568.1999.00786.x, 10564371.